| SC 13D | 2016-03-24 | Frazier Healthcare VI, L.P. | COLLEGIUM PHARMACEUTICAL, INC | 1,877,332 | 9.1% | EDGAR |
| SC 13G/A | 2016-02-16 | RA CAPITAL MANAGEMENT, LLC | COLLEGIUM PHARMACEUTICAL, INC | 857,683 | 3.7% | EDGAR |
| SC 13G | 2016-02-16 | TPG Group Holdings (SBS) Advisors, Inc. | COLLEGIUM PHARMACEUTICAL, INC | 1,325,263 | 5.7% | EDGAR |
| SC 13G | 2016-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | COLLEGIUM PHARMACEUTICAL, INC | 1,401,001 | 6.0% | EDGAR |
| SC 13G | 2016-02-10 | Skyline Venture Partners V LP | COLLEGIUM PHARMACEUTICAL, INC | 2,949,916 | 14.3% | EDGAR |
| SC 13G | 2016-01-22 | Boston Millennia Partners II Limited Partnership | COLLEGIUM PHARMACEUTICAL, INC | 4,666 | 4.3% | EDGAR |
| SC 13G | 2016-01-13 | HealthCor Management, L.P. | COLLEGIUM PHARMACEUTICAL, INC | 1,200,000 | 5.1% | EDGAR |
| SC 13G | 2015-09-22 | Longitude Capital Partners, LLC | COLLEGIUM PHARMACEUTICAL, INC | 3,321,842 | 16.1% | EDGAR |
| SC 13D | 2015-05-21 | Longitude Capital Partners, LLC | COLLEGIUM PHARMACEUTICAL, INC | 3,321,842 | 16.1% | EDGAR |
| SC 13G | 2015-05-15 | RA CAPITAL MANAGEMENT, LLC | COLLEGIUM PHARMACEUTICAL, INC | 1,545,410 | 7.8% | EDGAR |